Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Lymph Nodes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Esophagectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Jian-Hua Fu
19952018
No photo of Tie-Hua Rong
19862018
No photo of Si-Yu Wang
20002018

Research Output 1986 2018

Adjuvant radiotherapy, chemotherapy or surgery alone for high-risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trial

Guo, X., Fang, W., Li, Z., Yu, Z., Rong, T-H., Fu, J-H., Han, Y., Tan, L., Chen, C., Liu, S., Liao, Y., Xiao, G., Wei, Y., Zhu, C., Li, H., Luo, J. & Xing, W., Dec 1 2018, In : Thoracic Cancer. 9, 12, p. 1801-1806 6 p.

Research output: Contribution to journalArticle

Adjuvant Radiotherapy
Adjuvant Chemotherapy
Randomized Controlled Trials
Recurrence
Esophageal Squamous Cell Carcinoma

Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy

Liu, Z., Ou, W., Li, N. & Wang, S-Y., Oct 1 2018, In : Thoracic Cancer. 9, 10, p. 1285-1290 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Drug Therapy
Vascular Endothelial Growth Factor Receptor-2
Disease-Free Survival
Therapeutics
Endosonography
Esophageal Squamous Cell Carcinoma